Insight Enterprises to Present at Investor Conference
Insight Enterprises, Inc. (Nasdaq: NSIT) (the "Company") today announced that it is scheduled to participate in the following upcoming investor conference:
22nd Annual Needham Growth Conference
Tuesday, January 14, 2020, 8:00 AM ET
Lotte New York Palace Hotel, New York
Participants: Glynis Bryan, CFO and Helen Johnson, SVP, Finance
The Insight presentation will be broadcast live over the Internet at https://investor.insight.com/ where you can also view other recent Webcasts, slide presentations and other investor information.
About Insight
Insight Enterprises, Inc. is a Fortune 500 global IT provider helping businesses of all sizes ? from small and medium sized firms to worldwide enterprises, governments, schools and health care organizations ? define, architect, implement and manage Intelligent Technology SolutionsTM. Insight empowers its customers to manage their IT environments so they can drive meaningful business outcomes today and transform their operations for tomorrow. Discover more at www.insight.com.
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
